Malaguarnera M, Pistone G, Astuto M, Dell'Arte S, Finocchiaro G, Lo Giudice E, Pennisi G: L-Carnitine in the treatment of mild or moderate hepatic encephalopathy
The synthesis of findings from multiple investigations (Azzam et al., Mitchell et al., Krajnc et al.) fortifies the existing evidence base, enhancing the validity and applicability of the conclusions regarding the benefits of GLP-1 RAs in the management of IIH
16 These neurons project to widespread, but discrete, GLP-1R-expressing brain areas
Safety advantage: Unlike HGH, AOD-9604 does not significantly impact IGF-1, insulin sensitivity, or blood sugar regulation Therapeutic potential: Initially investigated as an anti-obesity drug, it has since gained attention in the wellness and peptide therapy communities for weight loss and metabolic health
Other positive points of the current study include almost the full list of monitoring data
doi: 10.1007/s12026-016-8873-z 235 Kopitar-JeralaN